The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else.

US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly ...

Dr. Vinay Prasad, the new director of the FDA's Center for Biologics Evaluation and Research, explained that the changes aim ...

The FDA says the new approach will aim to balance a timely approval process for vaccines, while also weighing “the need for ...

Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...

Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...